Holen Sie sich die Stockscreener-App
4.94
2.07%
0.10
Handel nachbörslich:
5.04
0.10
+2.02%
Schlusskurs vom Vortag:
$4.84
Offen:
$4.8356
24-Stunden-Volumen:
554.18K
Relative Volume:
8.00
Marktkapitalisierung:
$52.19M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.0014
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+3.13%
1M Leistung:
+13.56%
6M Leistung:
-41.40%
1J Leistung:
-59.71%
1-Tages-Spanne:
$4.76
$5.02
1-Wochen-Bereich:
$4.53
$5.05
52-Wochen-Spanne:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Firmenname
Avalo Therapeutics Inc
Sektor
Branche
Telefon
410-522-8707
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Vergleichen Sie AVTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
4.94 | 52.19M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Jefferies | Buy |
| 2025-03-25 | Eingeleitet | Stifel | Buy |
| 2025-02-28 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | Wedbush | Outperform |
| 2024-12-19 | Eingeleitet | BTIG Research | Buy |
| 2024-10-24 | Eingeleitet | H.C. Wainwright | Neutral |
| 2024-04-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten
(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com
Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria
Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus
Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May - Defense World
AVTX Virtual Meeting Scheduled for June 23 by BTIG | AVTX Stock News - GuruFocus
Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) PT at $30.00 - Defense World
Avalo Therapeutics Signs New Sales Agreement - TipRanks
Avalo Therapeutics Highlights AVTX-009 Potential in HS Market - TipRanks
Northern Trust Corp Invests $168,000 in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World
Avalo Therapeutics (NASDAQ:AVTX) Upgraded at HC Wainwright - Defense World
H.C. Wainwright upgrades Avalo Therapeutics stock to buy - Investing.com
Avalo Therapeutics assumed with a Buy at H.C. Wainwright - TipRanks
H.C. Wainwright upgrades Avalo Therapeutics stock to buy By Investing.com - Investing.com South Africa
AVTX: Avalo Therapeutics Receives Buy Rating with $15 Target Pri - GuruFocus
Avalo Therapeutics (AVTX) Receives Buy Rating from H.C. Wainwright | AVTX Stock News - GuruFocus
Cardax (OTCMKTS:CDXI) and Avalo Therapeutics (NASDAQ:AVTX) Head-To-Head Analysis - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - Defense World
Avalo Therapeutics to Participate in Upcoming Investor Conferenc - GuruFocus
Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00 - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Bought by Tower Research Capital LLC TRC - Defense World
Strong Cash Position Secures AVTX Through 2027 | AVTX Stock News - GuruFocus
Avalo Therapeutics Reports Improved Financial Performance - TipRanks
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire
Avalo Therapeutics reports Q1 EPS ($1.25) vs. ($141.14) last year - TipRanks
Avalo Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
AVTX Advances Phase 2 LOTUS Trial, Targets 2026 Data | AVTX Stoc - GuruFocus
AVALO THERAPEUTICS Earnings Results: $AVTX Reports Quarterly Earnings - Nasdaq
Avalo Reports First Quarter 2025 Financial Results and Recent Bu - GuruFocus
Avalo Therapeutics Announces Leadership Change and Updates on AVTX-009 Phase 2 Trial for Hidradenitis Suppurativa - Nasdaq
Avalo Therapeutics, Inc. SEC 10-Q Report - TradingView
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates - GlobeNewswire Inc.
Avalo Therapeutics (AVTX) Expected to Announce Quarterly Earnings on Monday - Defense World
Avalo Therapeutics Updates on AVTX-009 and LOTUS Trial - TipRanks
15,323 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Acquired by Marshall Wace LLP - Defense World
When the Price of (AVTX) Talks, People Listen - news.stocktradersdaily.com
Avalo Therapeutics Enters $75 Million Sales Agreement With TD Cowen For Common Stock Offering - marketscreener.com
Geode Capital Management LLC Increases Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - Defense World
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference - The Manila Times
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 20.3% in March - Defense World
60,000 Shares in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Purchased by Bank of Montreal Can - Defense World
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $33.00 Average PT from Brokerages - Defense World
Avalo Therapeutics (AVTX) Sees New Options Listings for April | AVTX Stock News - GuruFocus
Seven new option listings and one option delisting on April 16th - TipRanks
Avalo Therapeutics Reports 2024 Financial Results - TipRanks
Advanced Cancer Pain Management Therapeutics Market Size in 7MM - openPR.com
(AVTX) On The My Stocks Page - news.stocktradersdaily.com
Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avalo Therapeutics Inc-Aktie (AVTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Almenoff June Sherie | Director |
Nov 12 '24 |
Buy |
12.50 |
500 |
6,250 |
500 |
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):